Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease

Peng et al. [1] concluded that there is a causal influence of non-alcoholic fatty liver disease (NAFLD), presently classified as metabolic dysfunction-associated fatty liver disease (MAFLD), on arterial stiffness (AS) though without enough evidence signifying a causal connection of NAFLD/MAFLD with cardio-cerebrovascular disease (C-CVD). The authors considered that other metabolic syndrome (MetS)-related components might partly account for the relationship between NAFLD/MAFLD and C-CVD; such relationship may be influenced with different confounding factors [1].

Source: Metabolism - Clinical and Experimental - August 5, 2022 Category: Biomedical Science Authors: Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Liatsos, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Elisabeth Vardaka, Dimitra Gialambrinou, Georgios Kotronis, Michael Doulberis Source Type: research